Last year, two Connecticut lawmakers successfully pushed a comprehensive drug-pricing transparency law, and this year they have their sights set on bigger changes. Senate Deputy Minority Leader Matthew Lesser (D) and Rep. Sean Scanlon (D), co-chairs of a key state legislative committee, are pushing a grab bag bill of drug-pricing policies including cracking down on settlements that delay generic drug entry, allowing small businesses and individuals to join the state’s pharmacy benefit contract, studying drug importation and banning retroactive fees...